Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes

Published:2018-03-01 Issue:3 Volume:3 Page:234
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Chiarito Mauro¹²,Cao Davide¹²,Cannata Francesco¹²,Godino Cosmo³,Lodigiani Corrado²,Ferrante Giuseppe¹²,Lopes Renato D.⁴,Alexander John H.⁴,Reimers Bernhard¹²,Condorelli Gianluigi¹²,Stefanini Giulio G.¹²

Affiliation:

1. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy

2. Cardio Center, Humanitas Research Hospital, Rozzano-Milan, Italy

3. Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy

4. Duke Clinical Research Institute, Duke Health, Durham, North Carolina

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor XI inhibition in patients with acute coronary syndrome;European Heart Journal Supplements;2024-04

2. Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Clinical Medicine;2024-03-31

3. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-24

4. Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence;Current Problems in Cardiology;2024-01

5. Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients;Clinical Therapeutics;2024-01